News Articles

      • 13 December, 2018

    ISSCR Testimony in U.S. Congress Regarding Need for Fetal Tissue Research

    In written and oral testimony before the U.S. House of Representatives Oversight and Government Reform Committee today, former ISSCR president Sally Temple describes fetal tissue research as essential in studying and developing therapies for cancer, HIV, Zika, tuberculous, and other devastating diseases.
    Full story
      • 5 December, 2018

    2018 ISSCR Year in Review

    Stem cell science and regenerative medicine has made great progress in 2018, with significant clinical trials underway in several research areas, and advances in understanding that are illuminating new research pathways. The role of the ISSCR in supporting the research and its responsible translation to the clinic has never been more important. I want to highlight for you some of ISSCR’s work throughout the year that I believe helps advance science, give voice to our members, and sustain this ever-evolving field.
    Full story
      • 26 November, 2018

    ISSCR Comments on Reports of Chinese Scientists Performing Genome-Editing During Fertility Treatment

    Reports indicate that scientists in China have used CRISPR-mediated genome editing during in vitro fertilization to modify the genetic material of two embryos that were subsequently implanted into a patient, leading to the birth of two babies. As ISSCR and a number of other organizations have previously stated, the use of nuclear genome editing technologies, such as CRISPR, during fertility treatment is premature and should not be attempted at this time.
    Full story
      • 21 November, 2018

    ISSCR Comments to FDA Regarding ClinicalTrials.gov

    In a letter to the U.S. Food and Drug Administration (FDA), the ISSCR commented on proposed industry guidance for "Civil Money Penalties Relating to the ClinicalTrials.gov Data Bank."
    Full story
      • 16 November, 2018

    ISSCR Applauds FDA, FTC for Holding Deceptive Stem Cell Clinics Accountable

    The U.S. Food and Drug Administration has issued a warning letter to StemGenex of San Diego after an investigation found its cellular therapy does not conform with good manufacturing practice requirements, is being illegally marketed to treat conditions for which it has not been proven safe or effective, and is putting patients at risk.
    Full story
      • 16 November, 2018

    New Perspectives in Stem Cell Reports

    In this month's issue of the ISSCR journal, 2018 award recipients Graziella Pellegrini and Michele De Luca (Innovation Award), and Connie Eaves (Tobias Lecture), share perspectives on their science, and scientists write about the ethical challenges of premature delivery of stem cell-based therapies.
    Full story
      • 12 November, 2018

    Convergence of Stem Cell Science and Medicine

    Stem cell research is moving ever more deliberately toward the clinic with increasing momentum and is recognized as one of the most promising approaches for developing new kinds of medicines. The rapid advances in this field are having profound effects on how researchers conceive and pursue their work in traditional academic or research institutions and in commercial enterprises.
    Full story
      • 16 October, 2018

    ISSCR Letter to U.S. Department of Transportation re Transportation of Animals for Research

    The ISSCR writes in support of the National Association for Biomedical Research (NABR) complaint requesting relief from discriminatory airline carriage policies that impede the transportation of animals for biomedical research.
    Full story
      • 5 October, 2018

    Developing Trainees, Expanding Horizons

    I take seriously my responsibility to support and nurture future generations of stem cell scientists. Indeed, it is critical for all of us in this evolving field to help trainees and others coming up in the field, to ensure they have opportunities to learn, grow, make connections, and share their science.
    Full story
      • 2 October, 2018

    ISSCR Comments on Horizon Europe

    The ISSCR has responded to the European Commission proposal and the European Parliament's amendments for Horizon Europe, the seven-year research and innovation funding program to follow Horizon 2020.
    Full story
      • 2 October, 2018

    ISSCR Voice is Heard on Capitol Hill

    In mid-September, the U.S. Senate debated and passed a spending bill that included an increase in funding for the Department of Health and Human Services but did not include a ban on federal funding for fetal tissue research. ISSCR treasurer Arnold Kriegstein visited Senate and House leaders and staff on Capitol Hill shortly after the vote to voice appreciation for the Senate effort.
    Full story
      • 27 September, 2018

    ISSCR Responds to U.S. Department of Health and Human Services Decision Regarding Fetal Tissue Research

    The ISSCR is troubled by the HHS decision to “conduct a comprehensive review of all fetal tissue research.” The directive appears to come after intensive lobbying efforts by special interest groups with the goals of delaying or curtailing scientific research that relies on fetal tissue.
    Full story
      • 10 September, 2018

    ISSCR Journal Focuses on Women in Stem Cell Science; Reflections by CEO Nancy Witty

    The ISSCR has always had strong female leaders, and many of them are featured in the September and October editions of Stem Cell Reports.
    Full story
      • 6 September, 2018

    Energizing for Renewed Focus

    Many of us find time in the summer to reflect on work and recharge our batteries. Vacations, visits with friends, and time with family all help get away from everyday concerns in the lab and gain some perspective to inform the scientific path for the year ahead.
    Full story
      • 23 August, 2018

    Nominate for ISSCR Awards and Leadership Positions

    The ISSCR is soliciting nominations to honor exceptional and innovative research and support for young scientists, through its extensive awards program. It also invites members to nominate candidates to serve on the ISSCR board of directors.
    Full story